Carregant...
REDD1 functions at the crossroads between the therapeutic and adverse effects of topical glucocorticoids
Cutaneous atrophy is the major adverse effect of topical glucocorticoids; however, its molecular mechanisms are poorly understood. Here, we identify stress-inducible mTOR inhibitor REDD1 (regulated in development and DNA damage response 1) as a major molecular target of glucocorticoids, which mediat...
Guardat en:
| Publicat a: | EMBO Mol Med |
|---|---|
| Autors principals: | , , , , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BlackWell Publishing Ltd
2015
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4309667/ https://ncbi.nlm.nih.gov/pubmed/25504525 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.15252/emmm.201404601 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|